AKT1 and liver cancer: In conclusion, knockdown of BAP31 inhibited cell proliferation, migration, and invasion in liver cancer by suppressing PI3K/AKT/mTOR signaling pathways, thus providing a potential novel therapeutic target for the diagnosis and treatment of liver cancer.